After two years characterized by layoffs, pipeline reorganizations, FDA delays and clinical holds, Novavax CEO John Jacobs ...
"This is a new chapter in the history of our company," Novavax CEO John Jacobs told Yahoo Finance in an interview Friday. Novavax struggled after its COVID-19 vaccine was delayed by manufacturing ...
"Today, we announce the beginning of an exciting new chapter for Novavax with the launch of a strategically important ...
Novavax’s COVID-19 vaccine produced higher ... In this video from JPM 2025, pharmaphorum chats with SIFI CEO and Chairman Fabrizio Chines about a new treatment for acanthamoeba keratitis.
Novavax has said it intends to file for approval ... In this video from JPM 2025, pharmaphorum chats with SIFI CEO and Chairman Fabrizio Chines about a new treatment for acanthamoeba keratitis.